Owning a pet can be a roller coaster. There are the highs, like when your dog greets you with a full-body wiggle when you return home, or when your cat purrs loudly as you cuddle next to one another. Then there are the lows, ...
8 hours ago
0
0
The American Cancer Society estimates there are nearly 300,000 new cases of prostate cancer every year in the U.S., and approximately one in eight men will be diagnosed with prostate cancer in their lifetime. Prostate cancer ...
May 22, 2024
0
5
Novel therapeutic approaches are needed for children with diffuse midline glioma (DMG) and other recurrent high-grade central nervous system (CNS) tumors, aggressive brain cancers with poor prognoses. A type of immunotherapy ...
May 22, 2024
0
0
Research at the University of Oklahoma, in collaboration with The University of Tulsa, has resulted in a new method of screening for sleep disorders in children. The tool, the first of its kind, allows health professionals ...
May 22, 2024
0
0
Hepatocellular carcinoma (HCC), a prevalent form of cancer, profoundly influences the progression and prognosis of the disease through immune response mechanisms. The tumor microenvironment plays a pivotal role in fostering ...
May 22, 2024
0
0
With so many high-profile people diagnosed with cancer we are confronted with the stark reality the disease can strike any of us at any time. There are also reports certain cancers are increasing among younger people in their ...
May 22, 2024
0
2
Fatal overdoses in the U.S. fell for the first time in five years in 2023, according to preliminary estimates recently released by the Centers for Disease Control and Prevention, but UCLA researcher Joseph Friedman warns ...
May 22, 2024
0
0
Cambridge scientists have shown that problems regulating emotions—which can manifest as depression, anxiety and explosive outbursts—may be a core symptom of attention deficit hyperactivity disorder (ADHD).
May 22, 2024
0
44
Scientists have used breast cancer cells' weakness against themselves by linking a tumor-selective antibody with a cell-killing drug to destroy hard-to-treat tumors.
May 22, 2024
0
0
A novel therapy that reprograms immune cells to promote antitumor activity helped shrink hard-to-treat prostate and bladder cancers in mice, according to research from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel ...
May 21, 2024
0
405
